People

Inhaled drug developer Savara has announced the departures of its co-founders, CEO Rob Neville and President and Chief Business Officer Taneli Jouhikainen, who have resigned “to pursue other opportunities,” according to the company. Matthew Pauls, who… Read more . . .

Finnish nanonization specialist Nanoform has announced the appointments of Eric Peter and Sergie Letser to the company’s US business development team. In January 2020, Nanoform announced the appointment of Sally Langa as its new Head of… Read more . . .

Inhaled drug company MannKind Corporation has announced the appointment of Kevin Kaiserman as VP, Medical Affairs and Safety. Kaiserman, a pedicatric endocrinologist, was most recently in private practice. The company markets Afrezza inhaled insulin, which was… Read more . . .

Aerosol testing company Proveris Scientific has announced two new appointments: Joseph Werbeck rejoins the company as Senior Director of Technical Service and Mohamed Eldam joins Proveris as Applications Chemist. Werbeck, who will report to VP… Read more . . .

MannKind Corporation has announced the appointment of Alejandro Galindo as Chief Commercial Officer. Galindo most recently headed the Intensive Insulin Management business unit at Medtronic and previously served in a number of roles at GE Healthcare.… Read more . . .

Nephron Pharmaceuticals said that it has hired Rita Boucher as Chief Quality Officer and is promoting Jamie Shuster to Chief Projects Officer and Stephanie Simmonds to Chief Clinical Officer. Boucher previously worked in quality assurance… Read more . . .

Inhaled drug developer Senzer has announced major changes to its management “aimed at bolstering its commercialization strategy for COVID-19 and cannabinoid treatments.” In May 2020, Senzer announced that it was developing two inhaled anti-virals delivered… Read more . . .

Inhalation Sciences (ISAB) has named TFS Trial Form Support International Founder Daniel Spasic as Chairman of the Board. Spasic serves on the boards of several other companies, including connected spirometer maker NuvoAir. In May 2019,… Read more . . .

Inhaled drug CDMO Vectura has announced the appointments of Trevor Archbold, Robert Gurley, and Chris Vernall as Business Development Directors, reporting to recently appointed Chief Commercial Officer Mark Bridgewater. Archbold and Vernall will cover Europe;… Read more . . .